Literature DB >> 13876261

A method for evaluating disability in patients with Parkinson's disease.

G J CANTER, R DE LA TORRE, M MIER.   

Abstract

Entities:  

Keywords:  DISABILITY EVALUATION; PARALYSIS AGITANS/diagnosis

Mesh：

Year:  1961        PMID： 13876261     DOI： 10.1097/00005053-196108000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  43 in total

1.  The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years.

Authors:  M A Hely; J G Morris; R Traficante; W G Reid; D J O'Sullivan; P M Williamson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Age and activity effects on rate of bone mineral loss.

Authors:  D M Smith; M R Khairi; J Norton; C C Johnston
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

3.  Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity.

Authors:  L Henderson; C Kennard; T J Crawford; S Day; B S Everitt; S Goodrich; F Jones; D M Park
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

4.  Specificity of affective and autonomic symptoms of depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; A W Forrester; R G Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

5.  The effects of caring for a spouse with Parkinson's disease on social, psychological and physical well-being.

Authors:  F O'Reilly; F Finnan; S Allwright; G D Smith; Y Ben-Shlomo
Journal:  Br J Gen Pract       Date:  1996-09       Impact factor: 5.386

6.  Psychometric Properties of Activity, Self-Efficacy, and Quality-of-Life Measures in Individuals with Parkinson Disease.

Authors:  Vanina Dal Bello-Haas; Laura Klassen; M Suzanne Sheppard; Amy Metcalfe
Journal:  Physiother Can       Date:  2011-01-20       Impact factor: 1.037

Review 7.  Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data.

Authors:  B Scholtissen; F R J Verhey; H W M Steinbusch; A F G Leentjens
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

8.  Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias.

Authors:  H L Klawans; W J Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

9.  Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease.

Authors:  W J Weiner; H L Klawans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-10       Impact factor: 10.154

10.  Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.

Authors: 
Journal:  BMJ       Date:  1993-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.